ScreenerHero

RAMM RAMM Pharma Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · wearerammpharma.com
0.0100CAD0.00%Mkt Cap: 869466 $P/E: —

RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap869.47K USD
Enterprise Value885.80K USD
Revenue (TTM)924.09K USD
Gross Profit779.73K USD
Net Income (TTM)-6.49M USD
Revenue/Share0.01 CAD
Last Price0.0100 CAD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA75150G1046
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.31
EV/Revenue0.96
P/S0.94
P/B0.32
EPS (TTM)-0.07
EPS (Forward)—
52W Range
0.00502% of range0.2500
52W High0.2500 CAD
52W Low0.0050 CAD
Profitability
Gross Margin31.86%
Oper. Margin-373.34%
EBITDA Margin0.00%
Profit Margin-265.13%
ROE-156.37%
ROA-96.12%
Growth
Revenue Growth-70.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-771.93K USD
CapEx (TTM)—
FCF Margin40.55%
FCF Yield43.10%
Net Debt16.33K USD
Net Debt/EBITDA-0.01
Balance Sheet
Debt/Equity0.01
Current Ratio0.28
Quick Ratio0.16
Book Value/Sh0.03 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.119.39M
Float81.87M
Insiders31.43%
Institutions0.00%
Short Interest
Short Ratio0.6d
Short % Out.0.00%
Shares Short1.01K
Short (prev mo.)772
Technical
SMA 500.0084 (+19.0%)
SMA 2000.0173 (-42.0%)
Beta0.39
S&P 52W Chg16.45%
Avg Vol (30d)30.30K
Avg Vol (10d)40.08K
Technical Indicators
RSI (14)50.5
MACD-0.0003
MACD Signal-0.0004
MACD Hist.+0.0001
BB Upper0.0120 CAD
BB Middle0.0097 CAD
BB Lower0.0075 CAD
BB Width45.87%
ATR (14)0.0010 CAD
Vol Ratio (20d)0.00x